methoxamine has been researched along with Cirrhosis, Liver in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moeller, M; Pohl, S; Ripoll, C; Thonig, A; Zipprich, A | 1 |
| Alexander, IE; Angus, PW; Chin, R; Cunningham, SC; Habib, MR; Herath, CB; Mak, KY; Sharland, AF; Torresi, J | 1 |
| Casteleyn, C; D'Hondt, M; De Winter, B; Francque, S; Kwanten, W; Laleman, W; Michielsen, P; Pelckmans, P; Ramon, A; Van Dyck, C; Van Marck, E; Van Marck, V; Van Steenkiste, C; Verbeke, L; Vermeulen, W | 1 |
| Angus, PW; Burrell, LM; Herath, CB; Mak, K | 1 |
| Abrante, B; Abreu, P; de Ganzo, ZA; Felipe, V; González-Méndez, Y; Hernández-Guerra, M; Moreno, M; Quintero, E; Salido, E | 1 |
| Cadelina, GW; Groszmann, RJ; Loureiro-Silva, MR | 1 |
| Abraldes, JG; Bosch, J; Bragulat, M; Corominola, H; García-Pagán, JC; Graupera, M; Peralta, C; Rodés, J | 1 |
| Cadelina, GW; Groszmann, RJ; Iwakiri, Y; Loureiro-Silva, MR | 1 |
| Erhard, J; Gehnen, N; Heller, J; Molderings, GJ; Müller, A; Sauerbruch, T; Schepke, M; Spengler, U | 1 |
| Bosch, J; Bruix, J; Kravetz, D; Mastai, R; Navasa, M; Rodés, J; Viola, C | 1 |
10 other study(ies) available for methoxamine and Cirrhosis, Liver
| Article | Year |
|---|---|
Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis.
Topics: Animals; Blotting, Western; Dose-Response Relationship, Drug; Hepatic Artery; Hypertension, Portal; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Liver Cirrhosis; Male; Methoxamine; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Perfusion; Rats, Wistar; Vascular Resistance; Vasodilation | 2015 |
ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cytokines; Dependovirus; Disease Models, Animal; Enzyme Activation; Gene Expression; Genetic Therapy; Genetic Vectors; Hepatic Stellate Cells; Inflammation Mediators; Injections, Intraperitoneal; Lipid Peroxidation; Liver Cirrhosis; Liver Function Tests; Male; MAP Kinase Signaling System; Methoxamine; Mice; NADPH Oxidases; Neovascularization, Pathologic; Organ Specificity; Oxidative Stress; Peptidyl-Dipeptidase A; RNA, Messenger | 2015 |
Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture.
Topics: Analysis of Variance; Animals; Cytokines; Endothelin-1; Endothelium, Vascular; Fatty Liver; Hypertension, Portal; Liver; Liver Circulation; Liver Cirrhosis; Male; Methoxamine; Microscopy, Electron, Scanning; Microvessels; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Thromboxane-A Synthase; Vasoconstriction; Vasoconstrictor Agents | 2012 |
Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Endothelium, Vascular; In Situ Hybridization; Liver; Liver Circulation; Liver Cirrhosis; Male; Methoxamine; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Vasoconstrictor Agents | 2013 |
Chronic intermittent hypoxia aggravates intrahepatic endothelial dysfunction in cirrhotic rats.
Topics: Acetylcholine; Animals; Carbon Tetrachloride; Disease Models, Animal; Endothelium, Vascular; Hypoxia; Liver; Liver Cirrhosis; Male; Methoxamine; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Vasodilator Agents | 2013 |
Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas.
Topics: Adrenergic alpha-Agonists; Animals; Enzyme Inhibitors; Liver Circulation; Liver Cirrhosis; Male; Methoxamine; Microcirculation; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Vasoconstriction | 2003 |
Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic alpha-Agonists; Animals; Arachidonic Acid; Blood Pressure; Carbon Tetrachloride; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Isoenzymes; Liver Circulation; Liver Cirrhosis; Male; Membrane Proteins; Methoxamine; Nitric Oxide; Portal System; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Receptors, Thromboxane; RNA, Messenger; Thromboxane A2; Vascular Resistance | 2003 |
A liver-specific nitric oxide donor improves the intra-hepatic vascular response to both portal blood flow increase and methoxamine in cirrhotic rats.
Topics: Animals; Drug Interactions; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male; Mesenteric Artery, Superior; Methoxamine; Nitrates; Nitric Oxide Donors; Portal Vein; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid; Vascular Resistance; Vasoconstrictor Agents | 2003 |
Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis.
Topics: Adrenergic Agonists; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Case-Control Studies; Endothelium, Vascular; Female; Hepatic Artery; Humans; In Vitro Techniques; Isoproterenol; Liver Cirrhosis; Liver Transplantation; Male; Methoxamine; Middle Aged; Portal Vein; Receptors, Adrenergic; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
Topics: Azygos Vein; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male; Methoxamine; Middle Aged; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Splanchnic Circulation | 1987 |